跳至主要内容
临床试验/ISRCTN68010602
ISRCTN68010602进行中(未招募)Unknown

Medical comorbidities in bipolar disorder: clinical validation of risk factors and biomarkers to improve prevention and treatment

ERA PERMED0 个研究点目标入组 400 人开始时间: 2023年4月18日最近更新:
适应症

试验速览

阶段
Unknown
状态
进行中(未招募)
发起方
入组人数
400

研究概览

简要总结

2024 Protocol article in https://pubmed.ncbi.nlm.nih.gov/38703295/ (added 07/05/2024)

研究设计

研究类型
Observational

入排标准

性别
All

入选标准

  • 1. Primary diagnosis of BD I or BD II
  • 2. At least one contact with the mental health service in the last year
  • 3. Age 18-65 years
  • 4. Signed informed consent.

排除标准

  • 1. Plan to relocate in the subsequent year
  • 2. Severe psychiatric comorbidities (schizophrenia spectrum disorders)
  • 3. Severe cognitive impairment
  • 4. Severe substance/alcohol misuse

研究者

发起方
ERA PERMED

相似试验